{"id":"https://openalex.org/W1512867299","doi":null,"title":"IL-12/IL-23 inhibitors: the advantages and disadvantages of this novel approach for the treatment of psoriasis.","display_name":"IL-12/IL-23 inhibitors: the advantages and disadvantages of this novel approach for the treatment of psoriasis.","publication_year":2008,"publication_date":"2008-11-01","ids":{"openalex":"https://openalex.org/W1512867299","mag":"1512867299","pmid":"https://pubmed.ncbi.nlm.nih.gov/19145382"},"language":"en","primary_location":{"id":"pmid:19145382","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19145382","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Skin therapy letter","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5001542097","display_name":"Brenda L. Bartlett","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210098535","display_name":"Center for Clinical Studies","ror":"https://ror.org/00e8qrd29","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210098535"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"B L Bartlett","raw_affiliation_strings":["Center for Clinical Studies, Houston, TX, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Clinical Studies, Houston, TX, USA","institution_ids":["https://openalex.org/I4210098535"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023955219","display_name":"Megan Nicole Moody","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M N Moody","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5000478173","display_name":"Stephen Keith Tyring","orcid":"https://orcid.org/0000-0002-3337-0580","observed_orcids":["https://orcid.org/0000-0002-3337-0580"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"S K Tyring","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.5355,"has_fulltext":false,"cited_by_count":6,"citation_normalized_percentile":{"value":0.63788882,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":93},"biblio":{"volume":"13","issue":"8","first_page":"1","last_page":"4"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10469","display_name":"Psoriasis: Treatment and Pathogenesis","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10469","display_name":"Psoriasis: Treatment and Pathogenesis","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10837","display_name":"Dermatology and Skin Diseases","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11092","display_name":"Spondyloarthritis Studies and Treatments","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/psoriasis","display_name":"psoriasis","score":0.8650000095367432},{"id":"https://openalex.org/keywords/il-12-23-inhibitors","display_name":"IL-12/23 inhibitors","score":0.9610000252723694},{"id":"https://openalex.org/keywords/il-12","display_name":"IL-12","score":0.9900000095367432},{"id":"https://openalex.org/keywords/il-23","display_name":"IL-23","score":1.0},{"id":"https://openalex.org/keywords/biological-therapy","display_name":"biologic therapy","score":0.9649999737739563},{"id":"https://openalex.org/keywords/t-cell-mediated-inflammation","display_name":"T cell-mediated inflammation","score":0.7059999704360962},{"id":"https://openalex.org/keywords/cytokine-inhibition","display_name":"cytokine inhibition","score":0.7519999742507935},{"id":"https://openalex.org/keywords/psoriasis-pathogenesis","display_name":"psoriasis pathogenesis","score":0.6880000233650208},{"id":"https://openalex.org/keywords/treatment-efficacy","display_name":"treatment efficacy","score":0.7129999995231628}],"concepts":[{"id":"https://openalex.org/C2780564577","wikidata":"https://www.wikidata.org/wiki/Q179945","display_name":"Psoriasis","level":2,"score":0.8780943155288696},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6761792302131653},{"id":"https://openalex.org/C156730664","wikidata":"https://www.wikidata.org/wiki/Q23308590","display_name":"Interleukin 23","level":4,"score":0.6262223720550537},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.5352320075035095},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.5015857219696045},{"id":"https://openalex.org/C47348012","wikidata":"https://www.wikidata.org/wiki/Q99486570","display_name":"Interleukin 17","level":3,"score":0.4919273853302002},{"id":"https://openalex.org/C2780942790","wikidata":"https://www.wikidata.org/wiki/Q372016","display_name":"Pathogenesis","level":2,"score":0.4756167531013489},{"id":"https://openalex.org/C74172505","wikidata":"https://www.wikidata.org/wiki/Q194908","display_name":"Interleukin","level":3,"score":0.4662436842918396},{"id":"https://openalex.org/C2778690821","wikidata":"https://www.wikidata.org/wiki/Q212354","display_name":"Cytokine","level":2,"score":0.33982527256011963},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.09982049465179443}],"mesh":[{"descriptor_ui":"D000069549","descriptor_name":"Ustekinumab","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011565","descriptor_name":"Psoriasis","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D011565","descriptor_name":"Psoriasis","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D018664","descriptor_name":"Interleukin-12","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D053759","descriptor_name":"Interleukin-23","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"pmid:19145382","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19145382","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Skin therapy letter","raw_type":"Journal Article"},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.630.1801","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.630.1801","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"http://www.skintherapyletter.ca/stl/download/stl_13_8.pdf","raw_type":"text"},{"id":"mag:1512867299","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19145382","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9763000011444092,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":37,"referenced_works":["https://openalex.org/W100132251","https://openalex.org/W103134463","https://openalex.org/W1484955349","https://openalex.org/W1898779455","https://openalex.org/W1914772924","https://openalex.org/W1968055097","https://openalex.org/W1971392719","https://openalex.org/W1973703259","https://openalex.org/W1986291871","https://openalex.org/W1992683391","https://openalex.org/W2004260437","https://openalex.org/W2007876572","https://openalex.org/W2021520884","https://openalex.org/W2021795523","https://openalex.org/W2023313329","https://openalex.org/W2028947341","https://openalex.org/W2033774235","https://openalex.org/W2047842115","https://openalex.org/W2070974664","https://openalex.org/W2071343804","https://openalex.org/W2082225446","https://openalex.org/W2091371779","https://openalex.org/W2104747851","https://openalex.org/W2111415702","https://openalex.org/W2114577676","https://openalex.org/W2116956799","https://openalex.org/W2126162679","https://openalex.org/W2128705246","https://openalex.org/W2132121711","https://openalex.org/W2134520728","https://openalex.org/W2136801304","https://openalex.org/W2146581693","https://openalex.org/W2164721645","https://openalex.org/W2168043833","https://openalex.org/W2168860401","https://openalex.org/W2185536751","https://openalex.org/W2203856483"],"related_works":["https://openalex.org/W4243528263","https://openalex.org/W1970674826","https://openalex.org/W2781621836","https://openalex.org/W3120415678","https://openalex.org/W2884146134","https://openalex.org/W2125052122","https://openalex.org/W122158887","https://openalex.org/W3189225536","https://openalex.org/W2749177368","https://openalex.org/W81829693"],"abstract_inverted_index":{"Psoriasis":[0],"is":[1,9,58],"a":[2],"common":[3],"chronic":[4],"inflammatory":[5,17],"skin":[6],"disease":[7,27],"that":[8,54],"mediated,":[10],"in":[11,42],"part":[12],"by":[13],"the":[14,23,26,29,43,66,75,79],"body's":[15],"T-cell":[16],"response":[18],"mechanisms.":[19],"Further":[20],"insight":[21],"into":[22],"pathogenesis":[24],"of":[25,31,45,52,68],"and":[28,36,61],"role":[30],"various":[32],"cytokines,":[33],"particularly":[34],"interleukin(IL)-12":[35],"IL-23,":[37],"has":[38],"led":[39],"to":[40,77,87],"advances":[41],"treatment":[44],"this":[46],"disease.":[47],"A":[48],"relatively":[49],"new":[50,80],"class":[51],"drugs":[53],"inhibit":[55],"these":[56,69],"interleukins":[57],"being":[59],"developed":[60],"studied.":[62],"Current":[63],"data":[64],"regarding":[65],"efficacy":[67],"agents":[70],"show":[71],"they":[72],"may":[73],"have":[74],"potential":[76],"become":[78],"clinical":[81],"gold":[82],"standard":[83],"for":[84],"biologic":[85],"therapy":[86],"treat":[88],"psoriasis.":[89]},"counts_by_year":[{"year":2021,"cited_by_count":1},{"year":2019,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}